Valuation: Star Scientific, Inc.

Market Cap 2L 1L 1L 1L 2L 1.47Cr 2L 15.28L 6L 75.14L 6L 6L 2.41Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.76Cr 1.66Cr 1.51Cr 2.83Cr 192.08Cr 2.85Cr 20Cr 7.7Cr 98Cr 7.51Cr 7.35Cr 314.97Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+1.71%+63.08%+117.61% 1,05500Cr
+0.27%+0.92%+49.74%+73.35% 65TCr
+0.73%+0.68%+19.32%+74.90% 47TCr
-1.36%-0.39%+40.20%+41.03% 35TCr
+1.34%+5.47%+23.37%+31.30% 27TCr
-0.48%-0.06%+13.56%+12.36% 26TCr
+0.85%+6.35%+52.62%+54.39% 22TCr
+0.85%+1.10%+35.15%+101.82% 19TCr
-0.30%-10.41%-27.62%-61.04% 17TCr
Average +0.34%+0.74%+29.94%+49.52% 40.43TCr
Weighted average by Cap. +0.29%+1.32%+40.03%+69.79%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.39Cr -3.2Cr -2.91Cr -5.46Cr -369.73Cr -5.49Cr -38Cr -15Cr -188.67Cr -14Cr -14Cr -606.27Cr -68.45L -60.2L -56.93L -51.63L -96.97L -66Cr -97.53L -6.82Cr -2.63Cr -34Cr -2.57Cr -2.51Cr -107.74Cr
Net Debt -45T -39.58T -37.43T -33.95T -63.75T -43.2L -64.12T -4L -2L -22.04L -2L -2L -70.83L 1.99Cr 1.75Cr 1.65Cr 1.5Cr 2.81Cr 190.61Cr 2.83Cr 20Cr 7.64Cr 97Cr 7.46Cr 7.29Cr 312.56Cr
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-